2m 2m 2m 2m 2m 2m 2m
Ascendis Pharma Br (ASND)
NASDAQ
$264.15-$1.07 (-0.40%)
Price as of Jul 14, 2026 4:10 AM EDT- $15.0BMarket Cap
- 51.65%1-Year Change
- BiotechnologyIndustry
Ascendis Pharma Br (ASND)
$264.15-$1.07 (-0.40%)
ASND | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $265.22 | ||
Change | -$5.23 (-1.93%) | ||
Open | $267.02 | ||
High | $267.03 | ||
Low | $262.02 | ||
Previous Close | $270.45 | ||
Volume | 601,058 | ||
30-Day Average Volume | 971,601 | ||
1-Week Change | -1.01% | ||
1-Month Change | 21.63% | ||
1-Year Change | 51.65% | ||
3-Year Change | 203.00% | ||
5-Year Change | 112.99% | ||
Fundamentals | |||
Shares Outstanding | 62.0M | ||
Total Assets | $1.3B | ||
Market Cap | $15.0B | ||
Enterprise Value | $14.8B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue